Europe MRD Testing Market

2.1    MRD Testing Workflow Analysis
2.2    MRD Testing: Solid Tumor vs. Hematological Malignancy
2.3    Evolution of MRD Testing
2.4    Market Footprint
2.5    Market Size and Future Growth Potential
 

        3.1    Legal and Regulatory Framework of MRD Tests
                3.1.1    Europe
                3.1.2    European Union
        3.2    Supply Chain Analysis
                3.2.1    For Laboratory Developed Tests (LDTs)
                3.2.2    For In-Vitro Diagnostics (IVDs)

         4.1    Overview
         4.2    Europe
                4.2.1    Europe MRD Testing Market, by End User
                4.2.2    Europe MRD Testing Market, by Country

5.1 Overview
5.2 MRD Testing Ecosystem Active Players
5.3 Cergentis B.V.
      5.3.1 Company Overview
      5.3.2 Role of Cergentis B.V. in the MRD Testing Market
      5.3.3 Analyst Perspective
5.4 F. Hoffmann-La Roche Ltd
      5.4.1 Company Overview
      5.4.2 Role of F. Hoffmann-La Roche Ltd in the MRD Testing Market
      5.4.3 Financials
      5.4.1 Recent Developments
      5.4.2 Analyst Perspective
5.5 ICON plc
      5.5.1 Company Overview
      5.5.2 Role of ICON plc in the MRD Testing Market
      5.5.3 Financials
      5.5.4 Analyst Perspective

Table 1:    Impact Analysis of Market Drivers, Challenges, and Opportunities in the Europe MRD Testing Market
Table 2:    Comparison of Solid Tumor and Hematological Malignancy for MRD Testing
Table 3:    Comparison of FDA and EMA Draft Guidance

Figure 1:    Europe MRD Testing Market, $Billion, 2022 and 2033
Figure 2:    Share of Europe MRD Testing Market (by End User), $Billion, 2022 and 2033
Figure 3:    Share of MRD Testing Market (by Region), 2022
Figure 4:    MRD Testing Market: Research Methodology
Figure 5:    Primary Research Methodology
Figure 6:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 7:    Top-Down Approach (Segment-Wise Analysis)
Figure 8:    MRD Testing Workflow
Figure 9:    Evolution of the MRD Testing Market
Figure 10:    Europe MRD Testing Market Potential, $Billion, 2022-2033
Figure 11:    Laboratory Methods for MRD Detection
Figure 12:    Supply Chain Analysis of Laboratory-Developed Tests
Figure 13:    Supply Chain Analysis of In-Vitro Diagnostics
Figure 14:    MRD Testing Market Snapshot (by Region)
Figure 15:    Europe MRD Testing Market, $Billion, 2022-2033
Figure 16:    Europe: Market Dynamics
Figure 17:    Europe MRD Testing Market (by End User), $Million, 2022-2033
Figure 18:    Europe MRD Testing Market (by Country), $Million, 2022-2033
Figure 19:    Germany MRD Testing Market, $Million, 2022-2033
Figure 20:    France MRD Testing Market, $Million, 2022-2033
Figure 21:    U.K. MRD Testing Market, $Million, 2022-2033
Figure 22:    Italy MRD Testing Market, $Million, 2022-2033
Figure 23:    Spain MRD Testing Market, $Million, 2022-2033
Figure 24:    Rest-of-Europe MRD Testing Market, $Million, 2022-2033
Figure 25:    MRD Testing Market, Total Number of Companies Profiled
Figure 26:    Cergentis B.V.: Product Portfolio
Figure 27:    F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 28:    F. Hoffmann-La Roche Ltd: Overall Financials, 2020-2022
Figure 29:    F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2020-2022
Figure 30:    F. Hoffmann-La Roche Ltd: R&D Expenditure, 2020-2022
Figure 31:    ICON plc: Product Portfolio
Figure 32:    ICON plc: Overall Financials, $Million, 2019-2021
Figure 33:    ICON plc: Revenue (by Region), $Million, 2019-2021